Dr. Vaishali Sanchorawala, MD
Claim this profileBoston Medical Center
Area of expertise
Amyloidosis
Vaishali Sanchorawala, MD has run 4 trials for Amyloidosis. Some of their research focus areas include:
AL Amyloidosis
Vaishali Sanchorawala, MD has run 3 trials for AL Amyloidosis. Some of their research focus areas include:
Affiliated Hospitals
Boston Medical Center
Boston University Medical Center
Clinical Trials Vaishali Sanchorawala, MD is currently running
Venetoclax + Ixazomib + Dexamethasone
for AL Amyloidosis
This trial tests a combination of venetoclax, ixazomib citrate, and dexamethasone in patients with difficult-to-treat light chain amyloidosis. Venetoclax alone has shown promise in treating this condition, indicating its potential effectiveness and safety. The drugs work together to kill cancer cells and reduce inflammation.
Recruiting
1 award
Phase 1
22 criteria
Chemotherapy + Stem Cell Transplant
for Amyloidosis
This phase III trial compares the effect of adding a stem cell transplant with melphalan after completing chemotherapy with daratumumab, cyclophosphamide, bortezomib and dexamethasone (Dara-VCD) versus chemotherapy with Dara-VCD alone for treating patients with newly diagnosed amyloid light chain (AL) amyloidosis. Melphalan is a chemotherapy given prior to a stem cell transplant. Giving chemotherapy before a peripheral blood stem cell transplant helps kill cancer cells in the body and helps make room in the patient's bone marrow for new blood-forming cells (stem cells) to grow. The stem cells are then returned to the patients to replace the blood forming cells that were destroyed by the chemotherapy. Daratumumab is in a class of medications called monoclonal antibodies. It binds to a protein called CD38, which is found on some types of immune cells and cancer cells, including myeloma cells. Daratumumab may block CD38 and help the immune system kill cancer cells. Chemotherapy drugs, such as cyclophosphamide and bortezomib, work in different ways to stop the growth of cancer cells, either by killing the cells, by stopping them from dividing, or by stopping them from spreading. Dexamethasone is in a class of medications called corticosteroids. It is used to lower the body's immune response to help stop the growth of cancer cells. Giving a stem cell transplant with melphalan after Dara-VCD may kill more cancer cells in patients with newly diagnosed AL amyloidosis.
Recruiting
2 awards
Phase 3
3 criteria
More about Vaishali Sanchorawala, MD
Clinical Trial Related
4 years of experience running clinical trials · Led 5 trials as a Principal Investigator · 2 Active Clinical Trials
Treatments Vaishali Sanchorawala, MD has experience with
- Daratumumab
- Dexamethasone
- Pomalidomide
- STI-6129
- Daratumumab/rHuPH20
- Lenalidomide
Breakdown of trials Vaishali Sanchorawala, MD has run
Amyloidosis
AL Amyloidosis
Alzheimer's Disease
Multiple Myeloma
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Vaishali Sanchorawala, MD specialize in?
Vaishali Sanchorawala, MD focuses on Amyloidosis and AL Amyloidosis. In particular, much of their work with Amyloidosis has involved t(11;14) positive patients, or patients who are Stage I.
Is Vaishali Sanchorawala, MD currently recruiting for clinical trials?
Yes, Vaishali Sanchorawala, MD is currently recruiting for 2 clinical trials in Boston Massachusetts. If you're interested in participating, you should apply.
Are there any treatments that Vaishali Sanchorawala, MD has studied deeply?
Yes, Vaishali Sanchorawala, MD has studied treatments such as Daratumumab, Dexamethasone, Pomalidomide.
What is the best way to schedule an appointment with Vaishali Sanchorawala, MD?
Apply for one of the trials that Vaishali Sanchorawala, MD is conducting.
What is the office address of Vaishali Sanchorawala, MD?
The office of Vaishali Sanchorawala, MD is located at: Boston Medical Center, Boston, Massachusetts 02118 United States. This is the address for their practice at the Boston Medical Center.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.
Unbiased Results
We believe in providing patients with all the options.
Your Data Stays Your Data
We only share your information with the clinical trials you're trying to access.
Verified Trials Only
All of our trials are run by licensed doctors, researchers, and healthcare companies.